93 related articles for article (PubMed ID: 27508978)
1. Genetic effects of XRCC4 and ligase IV genes on human glioma.
Jiao K; Qin J; Zhao Y; Zhang H
Neuroreport; 2016 Sep; 27(14):1024-30. PubMed ID: 27508978
[TBL] [Abstract][Full Text] [Related]
2. Association of LIG4 and XRCC4 gene polymorphisms with the risk of human glioma in a Chinese population.
Su Y; Qi S; Dou C; Shuang L; Yan H
Int J Clin Exp Pathol; 2015; 8(2):2057-62. PubMed ID: 25973104
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma.
Liu Y; Zhou K; Zhang H; Shugart YY; Chen L; Xu Z; Zhong Y; Liu H; Jin L; Wei Q; Huang F; Lu D; Zhou L
Hum Mutat; 2008 Mar; 29(3):381-9. PubMed ID: 18165945
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of DNA double-strand break repair pathway genes and glioma susceptibility.
Zhao P; Zou P; Zhao L; Yan W; Kang C; Jiang T; You Y
BMC Cancer; 2013 May; 13():234. PubMed ID: 23663450
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
[TBL] [Abstract][Full Text] [Related]
6. Blood-based DNA methylation of DNA repair genes in the non-homologous end-joining (NEHJ) pathway in patient with glioma.
Zhou C; Tang H; Yu J; Zhuang D; Zhang H
Int J Clin Exp Pathol; 2015; 8(8):9463-7. PubMed ID: 26464705
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility.
Fu YP; Yu JC; Cheng TC; Lou MA; Hsu GC; Wu CY; Chen ST; Wu HS; Wu PE; Shen CY
Cancer Res; 2003 May; 63(10):2440-6. PubMed ID: 12750264
[TBL] [Abstract][Full Text] [Related]
8. A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients.
Chiu CF; Tsai MH; Tseng HC; Wang CL; Wang CH; Wu CN; Lin CC; Bau DT
Oral Oncol; 2008 Sep; 44(9):898-902. PubMed ID: 18164646
[TBL] [Abstract][Full Text] [Related]
9. XRCC4 controls nuclear import and distribution of Ligase IV and exchanges faster at damaged DNA in complex with Ligase IV.
Berg E; Christensen MO; Dalla Rosa I; Wannagat E; Jänicke RU; Rösner LM; Dirks WG; Boege F; Mielke C
DNA Repair (Amst); 2011 Dec; 10(12):1232-42. PubMed ID: 21982441
[TBL] [Abstract][Full Text] [Related]
10. Monoubiquitination of the nonhomologous end joining protein XRCC4.
Foster RE; Nnakwe C; Woo L; Frank KM
Biochem Biophys Res Commun; 2006 Mar; 341(1):175-83. PubMed ID: 16412978
[TBL] [Abstract][Full Text] [Related]
11. Significant association of XRCC4 single nucleotide polymorphisms with childhood leukemia in Taiwan.
Wu KH; Wang CH; Yang YL; Peng CT; Lin WD; Tsai FJ; Lin DT; Bau DT
Anticancer Res; 2010 Feb; 30(2):529-33. PubMed ID: 20332465
[TBL] [Abstract][Full Text] [Related]
12. The role of common variants of non-homologous end-joining repair genes XRCC4, LIG4 and Ku80 in thyroid cancer risk.
Gomes BC; Silva SN; Azevedo AP; Manita I; Gil OM; Ferreira TC; Limbert E; Rueff J; Gaspar JF
Oncol Rep; 2010 Oct; 24(4):1079-85. PubMed ID: 20811692
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy.
Yin M; Liao Z; Liu Z; Wang LE; O'Reilly M; Gomez D; Li M; Komaki R; Wei Q
Cancer; 2012 Jan; 118(2):528-35. PubMed ID: 21717429
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of polymorphisms of DNA double-strand break repair genes XRCC5, LIG4 and glioma].
He P; Li R; Luo W; Meng L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Jun; 39(6):641-645. PubMed ID: 35773772
[TBL] [Abstract][Full Text] [Related]
15. An analysis of single nucleotide polymorphisms of 125 DNA repair genes in the Texas genome-wide association study of lung cancer with a replication for the XRCC4 SNPs.
Yu H; Zhao H; Wang LE; Han Y; Chen WV; Amos CI; Rafnar T; Sulem P; Stefansson K; Landi MT; Caporaso N; Albanes D; Thun M; McKay JD; Brennan P; Wang Y; Houlston RS; Spitz MR; Wei Q
DNA Repair (Amst); 2011 Apr; 10(4):398-407. PubMed ID: 21296624
[TBL] [Abstract][Full Text] [Related]
16. C-Terminal region of DNA ligase IV drives XRCC4/DNA ligase IV complex to chromatin.
Liu S; Liu X; Kamdar RP; Wanotayan R; Sharma MK; Adachi N; Matsumoto Y
Biochem Biophys Res Commun; 2013 Sep; 439(2):173-8. PubMed ID: 23994631
[TBL] [Abstract][Full Text] [Related]
17. Requirement for XRCC4 and DNA ligase IV in alignment-based gap filling for nonhomologous DNA end joining in vitro.
Lee JW; Yannone SM; Chen DJ; Povirk LF
Cancer Res; 2003 Jan; 63(1):22-4. PubMed ID: 12517771
[TBL] [Abstract][Full Text] [Related]
18. Human DNA ligase IV and the ligase IV/XRCC4 complex: analysis of nick ligation fidelity.
Wang Y; Lamarche BJ; Tsai MD
Biochemistry; 2007 May; 46(17):4962-76. PubMed ID: 17407264
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer susceptibility and genetic polymorphism of DNA repair gene XRCC4 in Taiwan.
Hsu NY; Wang HC; Wang CH; Chang CL; Chiu CF; Lee HZ; Tsai CW; Bau DT
Cancer Biomark; 2009; 5(4):159-65. PubMed ID: 19729825
[TBL] [Abstract][Full Text] [Related]
20. Delineation of key XRCC4/Ligase IV interfaces for targeted disruption of non-homologous end joining DNA repair.
McFadden MJ; Lee WK; Brennan JD; Junop MS
Proteins; 2014 Feb; 82(2):187-94. PubMed ID: 23794378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
